학술논문

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models
Document Type
Article
Source
In: Frontiers in Immunology. (Frontiers in Immunology, 2023, 14)
Subject
Language
English
ISSN
16643224